Settings
DEPO [NASD]
DepoMed Inc.
Index- P/E14.07 EPS (ttm)1.34 Insider Own0.40% Shs Outstand58.74M Perf Week-0.53%
Market Cap1.11B Forward P/E46.80 EPS next Y0.40 Insider Trans-35.64% Shs Float58.55M Perf Month19.90%
Income78.90M PEG0.47 EPS next Q0.07 Inst Own90.10% Short Float9.96% Perf Quarter22.15%
Sales236.40M P/S4.69 EPS this Y241.50% Inst Trans0.29% Short Ratio6.09 Perf Half Y72.24%
Book/sh4.50 P/B4.19 EPS next Y311.22% ROA17.80% Target Price21.40 Perf Year58.35%
Cash/sh9.42 P/C2.00 EPS next 5Y30.00% ROE52.30% 52W Range9.85 - 20.51 Perf YTD17.07%
Dividend- P/FCF- EPS past 5Y34.10% ROI32.30% 52W High-8.04% Beta1.35
Dividend %- Quick Ratio5.40 Sales past 5Y31.00% Gross Margin94.00% 52W Low91.47% ATR0.83
Employees291 Current Ratio5.50 Sales Q/Q37.30% Oper. Margin36.60% RSI (14)59.88 Volatility4.40% 4.71%
OptionableYes Debt/Eq0.91 EPS Q/Q0.00% Profit Margin41.00% Rel Volume0.80 Prev Close18.42
ShortableYes LT Debt/Eq0.91 EarningsNov 05 AMC Payout0.00% Avg Volume957.93K Price18.86
Recom1.80 SMA206.38% SMA5014.81% SMA20032.85% Volume759,400 Change2.39%
Jan-16-15Upgrade ROTH Capital Neutral → Buy $25
Jan-16-15Reiterated RBC Capital Mkts Outperform $20 → $22
Dec-10-14Initiated RBC Capital Mkts Outperform $20
Jul-10-14Initiated WallachBeth Buy $17
Feb-25-13Downgrade WallachBeth Buy → Hold $8 → $7
Jan-05-12Initiated JMP Securities Mkt Outperform $8
Sep-30-11Initiated Auriga Buy $10
Feb-18-10Downgrade Merriman Buy → Neutral
Oct-21-09Initiated Caris & Company Buy $9
Oct-12-09Reiterated Merriman Buy $11.50 → $7.50
Oct-05-09Initiated Merriman Buy
Jun-20-08Initiated Roth Capital Buy $5
Mar-15-07Reiterated Thomas Weisel Overweight $8 → $6.50
Jan-20-15 09:00AM  East Bay's Depomed snags J&J pain-fighting drug in $1 billion deal at American City Business Journals -6.73%
Jan-16-15 04:34PM  U.S. markets break 5-day losing streak Yahoo Finance Contributors +14.45%
02:04PM  Mid-Day Market Update: U.S. Stocks Rise; SunTrust Shares Surge On Upbeat Earnings Benzinga
11:32AM  Depomed Hits High On Big Pain-Drug Deal With J&J at Investor's Business Daily
08:58AM  Depomed Surges 8% Following NUCYNTA Acquisition From Janssen Pharmaceuticals Benzinga
07:54AM  DepoMed upgraded by ROTH Capital Briefing.com
Jan-15-15 05:29PM  After-hours buzz: Intel, Regal, Depomed & more at CNBC
05:23PM  Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion Benzinga
05:21PM  DEPOMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial State EDGAR Online
05:00PM  Depomed Inc to Acquire the U.S. Rights to the NUCYNTA Franchise Call scheduled for 5:00 pm ET today CCBN
04:48PM  DepoMed to buy U.S. rights to Nucynta from J&J unit at MarketWatch
04:31PM  DepoMed to Buy U.S. Rights to Nucynta From J&J Unit at The Wall Street Journal
04:15PM  Depomed to pay $1 bln for J&J pain drug franchise Reuters
04:04PM  J&Js Pain Drug Is Depomeds Gain in $1.05 Billion Deal at Bloomberg
04:04PM  Depomed to Acquire U.S. Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended release tablets and NUCYNTA® (tapentadol) Oral Solution from Janssen Pharmaceuticals, Inc. for $1.05 billion PR Newswire
Nov-20-14 04:05PM  Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference PR Newswire
Nov-14-14 01:04PM  DEPOMED INC Financials EDGAR Online Financials
Nov-12-14 08:00AM  Depomed To Present At Stifel 2014 Healthcare Conference PR Newswire
Nov-08-14 07:07PM  10-Q for Depomed, Inc. Company Spotlight
Nov-06-14 04:28PM  DEPOMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
10:05AM  Another Solid Quarter For Depomed Zacks Small Cap Research
Nov-05-14 05:42PM  Depomed beats Street 3Q forecasts AP
04:30PM  Depomed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:11PM  DEPOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Depomed Reports Third Quarter 2014 Financial Results PR Newswire
07:07AM  Q3 2014 Depomed Inc Earnings Release - After Market Close CCBN
Oct-27-14 04:01PM  Depomed To Report Third Quarter Fiscal Year 2014 Financial Results On Wednesday, November 5, 2014 PR Newswire
Oct-07-14 12:08PM  5 places to play momentum at MarketWatch
Oct-03-14 12:00AM  OxyContin, Cialis Makers Dodge Court to Beat Patent Suits at Bloomberg
Oct-01-14 11:14AM  [video] Dan Tana's: Hollywood's Iconic Red-Sauce Joint at MarketWatch
Sep-30-14 02:54PM  Accelerated selling means its time to move to cash at MarketWatch
Sep-17-14 04:07PM  DEPOMED INC Files SEC form 8-K, Other Events EDGAR Online
Sep-09-14 04:05PM  DEPOMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Ex EDGAR Online
Sep-05-14 05:00PM  DEPOMED INC Files SEC form 8-K, Other Events EDGAR Online
02:34PM  Depomed Summary Judgment Motion Granted in Suit against FDA Seeking Orphan Drug Exclusivity for Gralise® (Gabapentin) PR Newswire
Sep-04-14 07:38AM  DEPOMED INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
07:00AM  Depomed Announces Pricing of Upsized $300 Million Convertible Senior Notes Due 2021 PR Newswire
Sep-02-14 04:18PM  DEPOMED INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
04:00PM  Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 PR Newswire
Aug-25-14 04:01PM  Depomed To Present At Morgan Stanley 2014 Global Healthcare Conference PR Newswire
Aug-21-14 04:02PM  DEPOMED INC Files SEC form 8-K, Other Events EDGAR Online
Aug-19-14 04:35PM  Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs Benzinga +13.53%
04:03PM  Nasdaq stocks posting largest percentage increases AP
11:32AM  Why DepoMed (DEPO) Stock Is Gaining Today at TheStreet
11:15AM  Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024 PR Newswire
Aug-06-14 04:43PM  DEPOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  Depomed Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:05PM  Depomed Reports Second Quarter 2014 Financial Results PR Newswire
07:07AM  Q2 2014 Depomed Earnings Release - After Market Close CCBN
Aug-04-14 05:08PM  DEPOMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04:01PM  Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer PR Newswire
Jul-25-14 04:01PM  Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 PR Newswire
Jul-17-14 05:27PM  DEPOMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online
05:15PM  2 Small-Cap Stocks Hedge Funds Love at Motley Fool
03:38PM  Depomed Announces District Court Order in ANDA Litigation PR Newswire
Jul-16-14 08:03AM  Depomed appoints Srinivas Rao as Chief Medical Officer theflyonthewall.com
08:00AM  Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer PR Newswire
Jul-09-14 09:04AM  Immune Pharma: A Top-Pick Based On Pipeline And Valuation at Seeking Alpha
Jun-27-14 06:03PM  Martin Marietta Materials Set to Join the S&P 500; United States Steel Corp. Set to Join the S&P MidCap 400 and Depomed Inc. Set to Join the S&P SmallCap 600 PR Newswire
Jun-20-14 04:06PM  DEPOMED INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jun-18-14 09:37AM  Exclusive: Steven Burrill Removed From Control Of Venture Fund For Unauthorized Payments at Forbes
08:00AM  Depomed To Present AT JMP Securities 2014 Healthcare Conference PR Newswire
Jun-10-14 11:00AM  TBUFF: A Pharmaceutical Company With Strong Upside Potential Zacks Small Cap Research
08:00AM  Depomed to Present at Wells Fargo 2014 Healthcare Conference PR Newswire
May-28-14 08:14AM  Mallinckrodt's NDA accepted by FDA, triggering $5M payment to Depomed at theflyonthewall.com
08:10AM  Mallinckrodt New Drug Application For MNK-155 Accepted For Review By FDA PR Newswire
May-27-14 04:05PM  Depomed To Present At Jefferies 2014 Global Healthcare Conference PR Newswire
May-23-14 05:07PM  DEPOMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securit EDGAR Online
May-13-14 10:03AM  Perilous Reversal Stock: DepoMed (DEPO) at TheStreet -5.58%
May-12-14 09:51AM  DepoMed (DEPO) Is Today's Dead Cat Bounce Stock at TheStreet +13.53%
May-09-14 04:36PM  DEPOMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online -15.64%
04:01PM  Depomed To Present At Bank of America Merrill Lynch Healthcare Conference And UBS Global Healthcare Conference PR Newswire
03:40PM  Review Of Depomed's First Quarter Results - Mind The GAAP at Seeking Alpha
01:12PM  Why DepoMed Inc. Shares Were Rocked at Motley Fool
May-08-14 08:00PM  DepoMed's (DEPO) CEO James Schoeneck on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha -9.27%
05:00PM  Depomed Earnings Call scheduled for 5:00 pm ET today CCBN
04:30PM  DEPOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:19PM  Depomed sees FY14 adjusted EPS 0c-16c, one estimate 31c at theflyonthewall.com
04:18PM  Depomed reports Q1 adjusted EPS (1c), one estimate 10c at theflyonthewall.com
04:01PM  Depomed Reports First Quarter 2014 Financial Results PR Newswire
09:02AM  Today's Top Health Care Stocks to Watch: Depomed Inc., Dendreon Corp., and Jazz Pharmaceuticals at Motley Fool
07:07AM  Q1 2014 Depomed Earnings Release - After Market Close CCBN
May-06-14 05:17PM  Depomed May Be Setting Up In A New Base at Investor's Business Daily
Apr-30-14 04:05PM  Depomed To Report First Quarter Fiscal Year 2014 Financial Results On Thursday, May 8, 2014 PR Newswire
Apr-14-14 01:04PM  Why DepoMed Inc. Shares Temporarily Spiked Higher at Motley Fool
08:07AM  Depomed enters into settlement agreement with two Gralise's ANDA filers theflyonthewall.com
08:00AM  Depomed Announces Settlements with Two Gralise® ANDA Filers PR Newswire
Apr-10-14 03:28PM  Averages, leading issues dictate high caution at MarketWatch -7.12%
Apr-04-14 10:17AM  Today's Dead Cat Bounce Stock Is DepoMed (DEPO) at TheStreet
Mar-31-14 03:45AM  BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month at Seeking Alpha
Mar-25-14 05:52PM  Depomed A 'Turtle' Gaining In Specialty Pharma Race at Investor's Business Daily
Mar-17-14 05:53PM  Depomed: 3 Different Insiders Have Sold Shares This Month at Seeking Alpha
04:45PM  DEPOMED INC Files SEC form 10-K, Annual Report EDGAR Online
Mar-16-14 05:16PM  Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook at Seeking Alpha
Mar-14-14 11:41AM  Put This Specialty Pharma In Your Portfolio at Seeking Alpha
Mar-13-14 09:09AM  Morning Movers in Biotech: Actavis plc, DepoMed, Inc. and Horizon Pharma, Inc. at Motley Fool +10.67%
Mar-12-14 06:50PM  DepoMed Management Discusses Q4 2013 Results - Earnings Call Transcript Optionetics
04:36PM  DEPOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  Depomed Earnings Call scheduled for 4:30 pm ET today CCBN
04:01PM  Depomed Reports Fourth Quarter and Full Year 2013 Financial Result PR Newswire
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other conditions, and diseases of the central nervous system in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; and Lazanda (fentanyl) Nasal Spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. The company is also involved in the clinical development of DM-1992 that completed a Phase II trial for Parkinson's disease. Depomed, Inc. sells its Gralise products to wholesalers and retail pharmacies. It has license and collaboration agreements with Abbott Products Inc.; Santarus, Inc.; Boehringer Ingelheim International GMBH; Ironwood Pharmaceuticals, Inc.; Janssen Pharmaceutica N.V.; Janssen Pharmaceuticals, Inc.; Mallinckrodt; Patheon Puerto Rico, Inc.; and Valeant Pharmaceuticals International, Inc. The company was founded in 1995 and is headquartered in Newark, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vargas Thadd MSenior VP, BDJan 20Option Exercise5.0319,00095,57088,443Jan 22 06:28 PM
Schoeneck James APresident and CEODec 19Option Exercise8.3640,700340,25256,432Dec 22 09:14 AM
Gosling Matthew MSenior VP, General CounselDec 02Sale15.858,819139,80832,501Dec 03 05:36 PM
Schoeneck James APresident and CEODec 02Sale15.8536,727582,23352,930Dec 03 05:35 PM
Vargas Thadd MSenior VP, BDDec 02Sale15.858,247130,74069,443Dec 03 05:35 PM
Moretti August JChief Financial OfficerDec 02Sale15.855,33984,63922,564Dec 03 05:35 PM
STAPLE PETER DDirectorNov 25Option Exercise5.0410,00050,40050,000Nov 26 04:38 PM
Gosling Matthew MSenior VP, General CounselNov 19Option Exercise6.1771,000438,07088,211Nov 21 08:00 PM
Gosling Matthew MSenior VP, General CounselNov 19Sale15.3671,0001,090,34717,211Nov 21 08:00 PM
Schoeneck James APresident and CEOAug 01Option Exercise6.1130,000183,30042,898Aug 04 10:46 AM
Vargas Thadd MSenior VP, BDMay 16Option Exercise3.0939,040120,63453,119May 19 05:34 PM
Gosling Matthew MSenior VP, General CounselMay 09Option Exercise6.174,00024,68015,396May 09 07:37 PM
Schoeneck James APresident and CEOMay 09Option Exercise4.5330,000135,750126,306May 09 07:37 PM
Vargas Thadd MSenior VP, BDMar 14Option Exercise5.0810,00050,80077,948Mar 14 08:46 PM
Gosling Matthew MSenior VP, General CounselMar 14Option Exercise3.0921,87567,59433,271Mar 14 08:46 PM
Vargas Thadd MSenior VP, BDMar 14Sale14.6963,869938,21014,079Mar 14 08:46 PM
Schoeneck James APresident and CEOMar 14Sale14.5417,000247,12499,306Mar 14 08:45 PM
Gosling Matthew MSenior VP, General CounselMar 14Sale14.7421,875322,32811,396Mar 14 08:46 PM